Apr 17, 2026 08:00AM
Nov 11, 2025 11:16PM
Nov 11, 2025 11:16PM
Nov 10, 2025 04:01PM
Nov 10, 2025 04:01PM
Nov 7, 2025 04:43PM
Jul 10, 2025 04:02PM Cogent Biosciences completes upsized $230 million public offering
Jul 10, 2025 04:01PM
Jul 9, 2025 05:59AM
Jul 8, 2025 09:36PM
Jul 8, 2025 04:49PM
Jul 8, 2025 04:26PM
Apr 25, 2025 08:08AM
Apr 9, 2024 09:00AM Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
Mar 29, 2024 04:10PM
Dec 7, 2023 09:05AM
Dec 7, 2023 09:00AM
Jun 9, 2023 04:01PM
Jun 7, 2023 05:15AM
Jun 6, 2023 08:25PM
Jun 6, 2023 04:06PM Cogent Biosciences (COGT) Announces Proposed $125M Share Offering
Jun 6, 2023 04:05PM
Apr 17, 2023 09:01AM
Apr 17, 2023 09:00AM
Mar 14, 2023 08:00AM
Feb 10, 2023 04:58PM
Jan 9, 2023 08:19AM
Jan 9, 2023 08:00AM Cogent Biosciences Announces Planned 2023 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Cancer Therapeutics
Nov 14, 2022 07:00AM
Jun 16, 2022 04:01PM
Jun 14, 2022 06:59AM
Jun 13, 2022 09:48PM
Jun 13, 2022 06:01AM
Jun 13, 2022 06:00AM
May 6, 2022 05:26PM Form S-3 Cogent Biosciences, Inc.
Feb 9, 2021 06:08AM
Dec 2, 2020 06:15AM
Dec 1, 2020 11:08PM
Nov 30, 2020 04:02PM
Nov 30, 2020 04:01PM
Jan 11, 2018 08:59AM
Jan 24, 2017 04:28PM Form S-3/A Cogint, Inc.
Dec 16, 2016 09:07AM

71,086 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All